Table 1.
Sex and age distribution of participants in clinical studies using single- and multi-herb products from the scoping review.
| Age Group | Single-Herb Products (n=) (See Section 2.1.1) |
Multi-Herb Products (n=) (See Section 2.1.2) |
Total (n=) and % * |
|---|---|---|---|
| 0–10 | 0 | 0 | 0 (0.0%) |
| 11–20 | 0 | 0 | 0 (0.0%) |
| 21–30 | 1 | 0 | 1 (1.4%) |
| 31–40 | 2 | 1 | 3 (4.1%) |
| 41–50 | 6 | 3 | 9 (12.3%) |
| 51–60 | 38 | 14 | 52 (71.2%) |
| 61–70 | 0 | 2 | 2 (2.7%) |
| 71–80 | 0 | 0 | 0 (0.0%) |
| 81–90 | 0 | 0 | 0 (0.0%) |
| 91–100 | 0 | 0 | 0 (0.0%) |
| Unknown | 5 | 1 | 6 (8.2%) |
| Sex | |||
| Male | 0 | 0 | 0 (0.0%) |
| Female | 51 | 19 | 70 (95.8%) |
| Unknown | 1 | 2 | 3 (4.1%) |
* Calculated as the percentage of the total of included articles excluding case reports (n = 73).